Join the Fungal Infections group to help and get support from people like you.
Fungal Infections News
Related terms: Fungal Infection, Infection, Fungal
Burden of Superficial Cutaneous Fungal Infection Quantified in U.S.
FRIDAY, Nov. 15, 2024 – The burden of superficial cutaneous fungal infections (SCFIs) among outpatient visits in the United States is high and increasing, according to a study published online Oct....
Expanded Admission Screening Protocol for Candida Auris Beneficial
FRIDAY, Nov. 8, 2024 – Health care facilities should consider initiating or expanding admission screening for Candida auris based on community prevalence rates, according to a study published online ...
First Cases of Sexually Transmitted Ringworm Reported in the U.S.
THURSDAY, Oct. 31, 2024 – Doctors in New York City are chronicling the first known U.S. cases of sexually transmitted ringworm (Trichophyton mentagrophytes). Until now, transmission of the fungal...
Doctors Report First U.S. Cases of Sexually Transmitted Ringworm Rash
THURSDAY, Oct. 31, 2024 – Doctors in New York City are describing the first known U.S. cases of sexually transmitted ringworm, which can cause a nasty rash that can take months to bring under...
Drug-Resistant Fungi Found in Commercial Flower Bulbs, Compost, Soil
WEDNESDAY, June 26, 2024 – A tough-to-treat, drug-resistant fungal infection may be as close as your local garden center, new research shows. Investigators at the University of Georgia (UGA) in...
Experts Warn of Drug-Resistant Jock Itch, Athlete's Foot
WEDNESDAY, June 5, 2024 – Drug-resistant fungal infections are appearing in the United States, resulting in highly contagious and tough-to-treat cases of ringworm, also known as jock itch or...
FDA Medwatch Alert: Fluconazole Injection, USP, (in 0.9 Percent Sodium Chloride) 200mg per 100ml: Recall - Elevated Impurity
ISSUE: Sagent has initiated a voluntary recall of one lot of Fluconazole Injection, USP, 200mg per 100mL to the user level due to the discovery of an out of specification impurity result detected...
FDA Approves Cresemba (isavuconazonium sulfate) For Fungal Infections
March 6, 2015 – The U.S. Food and Drug Administration today approved Cresemba (isavuconazonium sulfate), a new antifungal drug product used to treat adults with invasive aspergillosis and invasive...